Expanding access & empowering care.

Introducing FemSperm

Sperm preparation and analysis for the GYN office.

Get Started

Enhancing natural fertilization with innovative technology.

An icon of three sperm representing the word Direct. Targeted
An icon of a shield representing Safe. Safe
An icon of an award ribbon representing the word Reliable.
Effective
> 2X more
effective than IUI*
An icon of a coin floating above an upturned hand representing Cost-Effective. Affordable
Learn More Read Topline Data
*Based on per-cycle pregnancy rates in male factor infertility

FemaSeed is an intratubal insemination approach
without catheterization.


FemaSeed delivers washed sperm precisely into the selected fallopian tube by placement of a balloon catheter directly in the uterine cornu.  FemaSeed can be rotated to deliver sperm to the contralateral tube.

FemaSeed allows for expansion of practice services with a safe & affordable first-line infertility solution with improved efficacy demonstrated over historic IUI for low male sperm count.

Learn More

Clinical Data

Trial Design: Prospective, multi-center, unblinded pivotal clinical trial with historical control. Conducted under FDA Investigational Device Exemption (IDE) approval. (NCT0468847)

Top-Line Results1:

PRIMARY ENDPOINT
(for male-factor/unexplained fertility (1-20 million total motile sperm count, TMSC))
  • Pregnancy rate was 26.3% by subject (n=38) and 17.5% by cycle (n=57)
    • FemaSeed demonstrated a significantly higher pregnancy rate than the historical control
    (6.7% pregnancy rate by cycle for intrauterine insemination (IUI) with male factor (greater than 1 million TMSC))

    SAFETY
  • Adverse events were consistent with IUI.
    • 1. Liu, J. H., Glassner, M., Gracia, C. R., Johnstone, E. B., Schnell, V. L., Thomas, M. A., Morrison, L., Lee-Sepsick, K. (2024). FemaSeed Directional Intratubal Artificial Insemination for Couples with Male-Factor or Unexplained Infertility Associated with Low Male Sperm Count. J Gynecol Reprod Med, 8(2), 01-12.

    Market Research

    Number of participants: 1,000 infertile women
  • More than 7 in 10 women were extremely or very likely to consider insemination with FemaSeed
  • For those who received IVF, 88% would have preferred FemaSeed prior to moving on to IVF
  • 85% who received IUI would have preferred FemaSeed instead of IUI

    • FemaSeed Online Training


    Learn how to perform the FemaSeed procedure at your convenience. Our FemaSeed online training platform details the procedure step-by-step and provides valuable resources.

    Learn Now
    A computer monitor displaying FemaSeed training interface on LearnUpon.
    © 2025 Femasys Inc. All rights reserved. FemaSeed and StopLock are registered trademarks of Femasys Inc. | Terms of Use | Privacy Policy